Skip to main content
. 2016 Fall;16(3):263–269.

Figure 2.

Figure 2.

Left ventricular assist devices currently available in the United States. aThe HVAD trial for the DT indication was completed in 2015 and is awaiting FDA approval. bThe trial ongoing in 2016 for BTT and DT indications is the Momentum 3. BTT, bridge to transplantation; DT, destination therapy; FDA, US Food and Drug Administration. Images reproduced with permission from Thoratec Corp. and HeartWare.